Thompson Davis & Co’s Teladoc Health TDOC Stock Holding History

Thompson Davis & Co’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$28K	Buy	325 +25	+8%	+$1.78K	0.06%	287
2018 Q2	$17K	Buy	300 +175	+140%	+$8.55K	0.04%	347
2018 Q1	$5K	Hold	125	–	–	0.01%	492
2017 Q4	$4K	Sell	125 -200	-62%	-$6.64K	0.01%	549
2017 Q3	$11K	Buy	325 +125	+63%	+$4.1K	0.02%	671
2017 Q2	$7K	Sell	200 -50	-20%	-$1.46K	0.01%	765
2017 Q1	$6K	Buy	250 +125	+100%	+$2.6K	0.01%	859
2016 Q4	$2K	Sell	125 -15,000	-99%	-$255K	﹤0.01%	1037
2016 Q3	$277K	Sell	15,125 -625	-4%	-$11K	0.49%	44
2016 Q2	$252K	Buy	+15,750	New	+$184K	0.4%	60

Other funds holding TDOC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Thompson Davis & Co's TDOC Position: Q3 2018 in Review

Thompson Davis & Co increased its Teladoc Health (TDOC) stake by 8.3% in Q3 2018, buying an estimated $1.78K and bringing the position to 325 shares worth $28K. The position accounts for 0.06% of the portfolio, ranked #287.

Thompson Davis & Co first reported a position in TDOC in Q2 2016 and has held it in 10 quarters since. The position peaked at $277K in Q3 2016. 334 funds tracked by Wall St. Rank hold TDOC as of Q3 2018.

Thompson Davis & Co held 325 shares of Teladoc Health worth $28K as of Q3 2018.
Thompson Davis & Co bought 25 Teladoc Health shares in Q3 2018, an estimated $1.78K.
Teladoc Health made up 0.06% of Thompson Davis & Co's portfolio in Q3 2018, its #287 holding.
Thompson Davis & Co first reported a position in Teladoc Health in Q2 2016 and has held it in 10 quarters since.
Thompson Davis & Co's Teladoc Health position peaked at $277K in Q3 2016.
334 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.